Found: 4
Select item for more details and to access through your institution.
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation.
- Published in:
- Molecules, 2022, v. 27, n. 23, p. 8152, doi. 10.3390/molecules27238152
- By:
- Publication type:
- Article
Motifs in Natural Products as Useful Scaffolds to Obtain Novel Benzo[ d ]imidazole-Based Cannabinoid Type 2 (CB2) Receptor Agonists.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10918, doi. 10.3390/ijms241310918
- By:
- Publication type:
- Article
Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer Drugs.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6581, doi. 10.3390/ijms24076581
- By:
- Publication type:
- Article
Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3- b ]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands with High Affinity and Selectivity for the Cannabinoid Type 2 Receptor.
- Published in:
- Molecules, 2023, v. 28, n. 13, p. 4958, doi. 10.3390/molecules28134958
- By:
- Publication type:
- Article